| Literature DB >> 27168802 |
Minoru Tomizawa1, Fuminobu Shinozaki2, Kazunori Fugo3, Takafumi Sunaoshi2, Eriko Sugiyama2, Daisuke Kano2, Misaki Shite2, Ryouta Haga2, Yoshiya Fukamizu2, Satoshi Kagayama2, Rumiko Hasegawa4, Yoshinori Shirai4, Yasufumi Motoyoshi5, Takao Sugiyama6, Shigenori Yamamoto7, Takashi Kishimoto3, Naoki Ishige8.
Abstract
Differentiation between adenomyomatosis (ADM) and cancer of the gallbladder is necessary during diagnosis. Diffusion-weighted whole body imaging with background body signal suppression (DWIBS) images are able to indicate cancer and inflammation. The fusion of a DWIBS with a T2 weighted image (DWIBS/T2) facilitates both functional and anatomical investigations. In the present study, patient records and images from patients with surgically confirmed ADM from April 2012 to October 2014 were analyzed retrospectively. The enrolled patients, including 6 men (64.2±13.1 years) and 4 women (57.3±12.4 years) were subjected to DWIBS/T2 during routine clinical practice. The diagnosis of ADM was based on magnetic resonance cholangiopancreatography, transabdominal ultrasonography, and endoscopic ultrasonography; ADM was diagnosed definitively when cystic lesions were observed, indicating the Rokitansky-Aschoff sinus. A single patient was indicated to be positive by DWIBS/T2 imaging. The Rokitansky-Aschoff sinus revealed a relatively high signal intensity; however, it was not as strong as that of the spleen. The signal intensity was also high on an apparent diffusion coefficient map, suggesting T2 shine-through. The thickened wall displayed low signal intensity. The aforementioned results indicate that ADM may be negative upon DWIBS/T2 imaging; one false positive case was determined to be ADM, accompanied by chronic cholecystitis. The majority of patients with ADM displayed negative findings upon DWIBS/T2 imaging, and chronic cholecystitis may cause false positives.Entities:
Keywords: apparent diffusion coefficient; chronic cholecystitis; diffusion weighted imaging; magnetic resonance cholangiopancreatography
Year: 2016 PMID: 27168802 PMCID: PMC4840534 DOI: 10.3892/etm.2016.3126
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447